search
Back to results

RCT of Automated Conversational Agent vs. Treatment as Usual for the Management of Perinatal Mood

Primary Purpose

Cognitive Therapy, Depression, Postpartum, Mental Health

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Use of smartphone application (app)
Treatment as usual
Sponsored by
Stanford University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cognitive Therapy focused on measuring Automated conversational agent

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Postpartum day 0-7 after delivery
  • Medically stable and cleared for discharge
  • Owns smartphone
  • English-speaking (because all intervention materials are in English)

Exclusion Criteria:

  • Neonatal demise this admission
  • Intrauterine fetal demise this admission

Sites / Locations

  • Stanford University Department of Obstetrics and Gynecology

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Smartphone use + treatment as usual

Treatment as usual

Arm Description

Participants will receive treatment as usual and use the smartphone app for the management of mood.

Participants will receive treatment as usual.

Outcomes

Primary Outcome Measures

Mean change from baseline in Patient Health Questionnaire (PHQ-9) scores at 6 weeks post-delivery
PHQ-9 will be used to assess depression. The maximum score is 27. The scale is interpreted as follows: 0-4 no depression, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
Mean change from baseline in Edinburgh Postnatal Depression Scale Scores at 6 weeks
The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report used to measure postpartum depression (range 0-30, higher score indicates greater symptom burden). A score of >9 is indicative of perinatal major depression.

Secondary Outcome Measures

Mean change from baseline in Patient Health Questionnaire (PHQ-9) scores at 2 weeks post-delivery
PHQ-9 will be used to assess depression. The maximum score is 27. The scale is interpreted as follows: 0-4 no depression, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
Mean change from baseline in Patient Health Questionnaire (PHQ-9) scores at 4 weeks post-delivery
PHQ-9 will be used to assess depression. The maximum score is 27. The scale is interpreted as follows: 0-4 no depression, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
Mean change from baseline in Edinburgh Postnatal Depression Scale Scores at 2 weeks
The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report used to measure postpartum depression (range 0-30, higher score indicates greater symptom burden). A score of >9 is indicative of perinatal major depression.
Mean change from baseline in Edinburgh Postnatal Depression Scale Scores at 4 weeks
The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report used to measure postpartum depression (range 0-30, higher score indicates greater symptom burden). A score of >9 is indicative of perinatal major depression.

Full Information

First Posted
August 23, 2018
Last Updated
September 17, 2020
Sponsor
Stanford University
search

1. Study Identification

Unique Protocol Identification Number
NCT03646539
Brief Title
RCT of Automated Conversational Agent vs. Treatment as Usual for the Management of Perinatal Mood
Official Title
Randomized Clinical Trial of an Automated Conversational Agent Versus Treatment as Usual for the Management of Perinatal Mood
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
October 1, 2018 (Actual)
Primary Completion Date
July 4, 2019 (Actual)
Study Completion Date
July 4, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to investigate the efficacy of an evidence-based smartphone application (app) for the management of mood compared to treatment as usual alone among 135 women who have been discharged post-delivery from Labor and Delivery at Stanford Children's Health - Lucile Packard Children's Hospital. Using psychometrically validated surveys for depression, postpartum depression, and anxiety, this study will evaluate whether the smartphone app has a differential effect on the mental health of postpartum women as compared to treatment as usual.
Detailed Description
The intervention is a cognitive behavioral therapy (CBT) based automated conversational agent available as a mobile device smartphone application. When a user logs in with the app, it asks questions about that user, such as how they're feeling, and the user is able to type their response, similar to texting or messaging. The app is then available for use by the user anytime (24 hours per day 7 days per week), and will check in with the user to encourage mood tracking followed by tailored delivery of CBT-based tools and other general psychoeducation. This smartphone app interacts with conversational tones, and offers empathy and behavioral pattern insight to users. The app's artificial intelligence becomes more specific to a user over time, based on conversations. The app allows patients are able to immediately process and receive empathy for significant events and removes barriers traditionally limiting treatment access (cost, stigma, health care system navigability, and lack of childcare or transportation).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cognitive Therapy, Depression, Postpartum, Mental Health, Depression, Depressive Disorder, Anxiety, Telemedicine
Keywords
Automated conversational agent

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
201 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Smartphone use + treatment as usual
Arm Type
Experimental
Arm Description
Participants will receive treatment as usual and use the smartphone app for the management of mood.
Arm Title
Treatment as usual
Arm Type
Active Comparator
Arm Description
Participants will receive treatment as usual.
Intervention Type
Behavioral
Intervention Name(s)
Use of smartphone application (app)
Intervention Description
Use of a CBT-based automated conversational agent available as a mobile device smartphone application for the management of mood.
Intervention Type
Other
Intervention Name(s)
Treatment as usual
Intervention Description
Treatment as usual will include (but may not be limited to) the participant's 6-week postpartum follow-up visit with their obstetrics care team. Participants will be sent surveys to evaluate their depressive and anxiety symptoms.
Primary Outcome Measure Information:
Title
Mean change from baseline in Patient Health Questionnaire (PHQ-9) scores at 6 weeks post-delivery
Description
PHQ-9 will be used to assess depression. The maximum score is 27. The scale is interpreted as follows: 0-4 no depression, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
Time Frame
Baseline; 6 weeks post-delivery
Title
Mean change from baseline in Edinburgh Postnatal Depression Scale Scores at 6 weeks
Description
The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report used to measure postpartum depression (range 0-30, higher score indicates greater symptom burden). A score of >9 is indicative of perinatal major depression.
Time Frame
Baseline; 6 weeks post-delivery
Secondary Outcome Measure Information:
Title
Mean change from baseline in Patient Health Questionnaire (PHQ-9) scores at 2 weeks post-delivery
Description
PHQ-9 will be used to assess depression. The maximum score is 27. The scale is interpreted as follows: 0-4 no depression, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
Time Frame
Baseline; 2 weeks post-delivery
Title
Mean change from baseline in Patient Health Questionnaire (PHQ-9) scores at 4 weeks post-delivery
Description
PHQ-9 will be used to assess depression. The maximum score is 27. The scale is interpreted as follows: 0-4 no depression, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
Time Frame
Baseline; 4 weeks post-delivery
Title
Mean change from baseline in Edinburgh Postnatal Depression Scale Scores at 2 weeks
Description
The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report used to measure postpartum depression (range 0-30, higher score indicates greater symptom burden). A score of >9 is indicative of perinatal major depression.
Time Frame
Baseline; 2 weeks post-delivery
Title
Mean change from baseline in Edinburgh Postnatal Depression Scale Scores at 4 weeks
Description
The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report used to measure postpartum depression (range 0-30, higher score indicates greater symptom burden). A score of >9 is indicative of perinatal major depression.
Time Frame
Baseline; 4 weeks post-delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Postpartum day 0-7 after delivery Medically stable and cleared for discharge Owns smartphone English-speaking (because all intervention materials are in English) Exclusion Criteria: Neonatal demise this admission Intrauterine fetal demise this admission
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amy Judy, MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stanford University Department of Obstetrics and Gynecology
City
Stanford
State/Province
California
ZIP/Postal Code
94305
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28588005
Citation
Fitzpatrick KK, Darcy A, Vierhile M. Delivering Cognitive Behavior Therapy to Young Adults With Symptoms of Depression and Anxiety Using a Fully Automated Conversational Agent (Woebot): A Randomized Controlled Trial. JMIR Ment Health. 2017 Jun 6;4(2):e19. doi: 10.2196/mental.7785.
Results Reference
result

Learn more about this trial

RCT of Automated Conversational Agent vs. Treatment as Usual for the Management of Perinatal Mood

We'll reach out to this number within 24 hrs